Trxade Health Inc
MEDS - Insider Information
Get informed when a big investor buys or sells
+ FollowMarket Cap$8.63M
Close$
$-9.43
615.2% downside
Current Fair Value
615.2% downsideOvervalued by 615.2% based on the discounted cash flow analysis.
Insider Trades
Loading insider trades…
Congress Trades
Loading congress trades…
Share Statistics
| Market cap | $8.63 Million |
|---|---|
| Enterprise Value | $38.79 Million |
| Earnings per Share | $-71.5 |
| Beta | -1.52 |
| Outstanding Shares | 2,574,669 |
Return
| Return on Equity | 230324.93% |
|---|---|
| Return on Assets | -137130.30% |
| Return on Invested Capital | 706449.67% |
Valuation & Multiples
| P/E Ratio | -0.04 |
|---|---|
| PEG | -0.02 |
| Price to Sales | 0.01 |
| Price to Book Ratio | -0.23 |
| Enterprise Value to Revenue | 0.08 |
| Enterprise Value to EBIT | 0 |
| Enterprise Value to Net Income | -1 |
| Total Debt to Enterprise | 0.84 |
| Debt to Equity | -1.67 |
Revenue Sources
No data
Last Earnings Call
Report Date
August 17, 2026
EPS Estimate
-
Consensus analyst estimateRevenue Estimate
-
Consensus analyst estimateInstitutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
About Trxade Group Inc
9 employees
CEO: Shankar Hariharan
Scienture Holdings, Inc. operates as pharmaceutical company that focuses on development and commercialization of products for the treatment of central nervous system and cardiovascular diseases in the United States. The company develops ...